A randomized controlled pilot trial of a smoking cessation intervention for US women living with HIV: telephone-based video call vs voice call

Sun S Kim, Sabreen Darwish, Sang A Lee, Courtenay Sprague, Rosanna F DeMarco, Sun S Kim, Sabreen Darwish, Sang A Lee, Courtenay Sprague, Rosanna F DeMarco

Abstract

Background: People living with HIV smoke at a rate three times that of the general population. This randomized controlled pilot trial tested the feasibility and acceptability of a video-call smoking cessation intervention in women living with HIV and its preliminary efficacy compared with a voice-call smoking cessation intervention. The study focused on women due to a paucity of studies among this population, and women are less likely than men to quit smoking when provided with conventional treatment.

Methods: Participants in both arms received an HIV-tailored smoking cessation intervention comprising eight 30-minute weekly counseling sessions in conjunction with active nicotine patches for 8 weeks. The only difference between the two arms was the delivery mode of the intervention: via either telephone-based video or voice call. Survival analysis and a Cox proportional hazard regression model were performed to identify factors predicting 6-month prolonged abstinence from smoking.

Results: A video-call intervention was almost 30% less feasible than a voice-call intervention because women in their 50s and 60s or poorer women living in some southern states did not have access to video-call equipment. However, those who received the video-call intervention were more likely to complete the study than those who had the voice-call intervention. There was no difference in the acceptability of the two interventions. A survival analysis revealed that those in the video arm were significantly more likely to maintain smoking abstinence over the 6-month follow-up period than those in the voice arm (log rank χ 2=4.02, P<0.05).

Conclusion: Although a video-call intervention is less feasible than a voice-call intervention, the former seems to outperform the latter in achieving long-term smoking abstinence for women living with HIV, which may offer an advantage over establishing therapeutic alliance and visually monitoring their adherence to nicotine patches.

Clinical trial registration: ClinicalTrials.gov NCT02898597.

Keywords: HIV; smoking cessation intervention; video call; women.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
CONSORT diagram of the study.
Figure 2
Figure 2
Survival analysis of abstinence in video call group vs the voice call group.

References

    1. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23(6):582–590.
    1. Palella FJ, Baker RK, Moorman AC, et al. HIV Outpatient Study Investigators Mortality in the highly antiretroviral therapy era: changing causes of death and disease in the HIB outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34.
    1. Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Anti-retroviral Therapy clinical trial. Am J Public Health. 2010;100(10):1896–1903.
    1. Moscou-Jackson G, Commodore-Mensah Y, Farley J, Digiacomo M. Smoking-cessation interventions in people living with HIV infection: a systematic review. J Assoc Nurses AIDS Care. 2014;25(1):32–45.
    1. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–110.
    1. Vidrine DJ, Kypriotakis G, Li L, et al. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug Alcohol Depend. 2015;147:76–80.
    1. Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Res Infect Dis. 2013;57(4):608–615.
    1. Balfour L, Wiebe SA, Cameron WD, et al. An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus nicotine replacement therapy. AIDS Care. 2017;29(1):24–31.
    1. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–1445.
    1. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2):208–215.
    1. Stanton CA, Papandonatos GD, Shuter J, et al. Outcomes of a tailored intervention for cigarette smoking cessation among Latinos living with HIV/AIDS. Nicotine Tob Res. 2015;17(8):975–982.
    1. Ledgerwood DM, Yskes R. Smoking cessation for people living with HIV/AIDS: a literature review and synthesis. Nicotine Tob Res. 2016;18(12):2177–2184.
    1. Hessol NA, Weber KM, D’Souza G, et al. Smoking cessation and recidivism in the Women’s Interagency Human Immunodeficiency Virus Study. Am J Prev Med. 2014;47(1):53–69.
    1. Allen AM, Scheuermann TS, Nollen N, Hatsukami D, Ahluwalia JS. Gender differences in smoking behavior and dependence motives among daily and nondaily smokers. Nicotine Tob Res. 2016;18(6):1408–1413.
    1. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol. 1999;67(4):555–562.
    1. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res. 2003;5(1):111–116.
    1. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 2007;15(1):21–36.
    1. Mckee SA, O’Malley SS, Salovey P, Krishnan-Sarin S, Mazure CM. Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav. 2005;30(3):423–435.
    1. Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10(7):1245–1250.
    1. Smith PH, Kasza KA, Hyland A, et al. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2015;17(4):463–472.
    1. Xu J, Azizian A, Monterosso J, et al. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res. 2008;10(11):1653–1661.
    1. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction. 2012;107(10):1847–1856.
    1. Cepeda-Benito A, Reynoso JT, Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol. 2004;72(4):712–722.
    1. US Department of Health and Human Services (DHHS) Health Resources and Services Administration . A Guide to the Clinical Care of Women with HIV – 2013. Rockville, MA: U.S. Department of Health and Human Services; 2013.
    1. . Menlo Park: The Kaiser Family Foundation Women and HIV/AIDS in the United States; [Accessed March 6, 2014]. Available from:
    1. Hordacre B. The role of Telehealth to assist in-home tDCS: opportunities, promising results and acceptability. Brain Sci. 2018;8(6):E102.
    1. Rasekaba TM, Furler J, Young D, et al. Using technology to support care in gestational diabetes mellitus: quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM) Diabetes Res Clin Pract. 2018;142:276–285.
    1. Adams N, Hamilton N, Nelson EL, Smith CE. Using telemedicine to identify Depressive Symptomatology Rating Scale in a home parenteral nutrition population. J Technol Behav Sci. 2017;2(3–4):129–139.
    1. Johnson KE, Alencar MK, Coakley KE, et al. Telemedicine-based health coaching is effective for inducing weight loss and improving metabolic markers. Telemed J E Health. 2018 May 30; Epub.
    1. Harvey JB, Valenta S, Simpson K, Lyles M, McElligott J. Utilization of outpatient Telehealth services in parity and nonparity states 2010–2015. Telemed J E Health. 2018 May 30; Epub.
    1. Zilliacus E, Meiser B, Lobb E, Dudding TE, Barlow-Stewart K, Tucker K. The virtual consultation: practitioners’ experiences of genetic counseling by videoconferencing in Australia. Telemed J E Health. 2010;16(3):350–357.
    1. Moreno FA, Chong J, Dumbauld J, Humke M, Byreddy S. Use of standard Webcam and Internet equipment for telepsychiatry treatment of depression among underserved Hispanics. Psychiatr Serv. 2012;63(12):1213–1217.
    1. Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L. Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol. 2010;4(3):666–684.
    1. Kitamura C, Zurawel-Balaura L, Wong RK. How effective is video consultation in clinical oncology? A systematic review. Curr Oncol. 2010;17(3):17–27.
    1. Carlson LE, Lounsberry JJ, Maciejewski O, Wright K, Collacutt V, Taenzer P. Telehealth-delivered group smoking cessation for rural and urban participants: feasibility and cessation rates. Addict Behav. 2012;37(1):108–114.
    1. Jang Y, Chiriboga DA, Molinari V, et al. Telecounseling for the linguistically isolated: a pilot study with older Korean immigrants. Gerontologist. 2014;54(2):290–296.
    1. Haskins BL, Lesperance D, Gibbons P, Boudreaux ED. A systematic review of smartphone applications for smoking cessation. Transl Behav Med. 2017;7(2):292–299.
    1. Kim SS, Sitthisongkram S, Bernstein K, Fang H, Choi WS, Ziedonis D. A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings. Int J Womens Health. 2016;8:453–462.
    1. Richter KP, Shireman TI, Ellerbeck EF, et al. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation. J Med Internet Res. 2015;17(5):e113.
    1. Marhefka SL, Turner D, Lockhart E, Rivara A, Wang W, Shuter J. Meeting our patients “Where They Are”: video-group smoking cessation for people living with HIV. J Assoc Nurses AIDS Care. 2018;29(2):338–344.
    1. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. Geneva: World Health Organization; 2001.
    1. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, Inc; 1986.
    1. Fiore M, Jaen CR, Baker T, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services; 2008.
    1. Friis-Møller N, Sabin CA, Weber R, et al. Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.
    1. Kim S, Darwish S, Lee S, Demarco RF. A pilot study of a smoking cessation intervention for women living with HIV: study protocol. Open Access J Clin Trial. 2017;9:11–20.
    1. Fiore MC, Jaén C, Baker T. Treating Tobacco Use and Dependence: 2008 Update Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008. pp. 106–128.
    1. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197–207.
    1. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13–25.
    1. Benowitz NL, Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56(5):483–493.
    1. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–529.
    1. Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010;22(5):630–639.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–1127.
    1. de Meneses-Gaya C, Zuardi AW, de Azevedo Marques JM, Souza RM, Loureiro SR, Crippa JA. Psychometric qualities of the Brazilian versions of the Fagerström Test for Nicotine Dependence and the Heaviness of Smoking Index. Nicotine Tob Res. 2009;11(10):1160–1165.
    1. Huang CL, Lin HH, Wang HH. The psychometric properties of the Chinese version of the Fagerstrom Test for Nicotine Dependence. Addict Behav. 2006;31(12):2324–2327.
    1. Kim SS, Fang H, Difranza J, Ziedonis DM, Ma GX, Gx M. Gender differences in the Fagerström Test for Nicotine Dependence in Korean Americans. J Smok Cessat. 2012;7(1):1–6.
    1. Wellman RJ, Savageau JA, Godiwala S, et al. A comparison of the Hooked on Nicotine Checklist and the Fagerström Test for Nicotine Dependence in adult smokers. Nicotine Tob Res. 2006;8(4):575–580.
    1. Jhanjee S, Sethi H. The Fagerström test for nicotine dependence in an Indian sample of daily smokers with poly drug use. Nicotine Tob Res. 2010;12(11):1162–1166.
    1. Radzius A, Gallo JJ, Epstein DH, et al. A factor analysis of the Fagerström Test for Nicotine Dependence (FTND) Nicotine Tob Res. 2003;5(2):255–260.
    1. Yamada H, Acton GS, Tsoh JY. Differential item functioning of the English and Chinese versions of the Fagerstrom Test for Nicotine Dependence. Addict Behav. 2009;34(2):125–133.
    1. Raykov T. Scale reliability, Cronbach’s coefficient alpha, and violations of essential tau-equivalence with fixed congeneric components. Multivariate Behav Res. 1997;32(4):329–353.
    1. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271–283.
    1. Hu SC, Lanese RR. The applicability of the theory of planned behavior to the intention to quit smoking across workplaces in southern Taiwan. Addict Behav. 1998;23(2):225–237.
    1. Radloff LS. The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
    1. Xu J, Azizian A, Monterosso J, et al. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res. 2008;10(11):1653–1661.
    1. Natamba BK, Achan J, Arbach A, et al. Reliability and validity of the center for epidemiologic studies-depression scale in screening for depression among HIV-infected and -uninfected pregnant women attending antenatal services in northern Uganda: a cross-sectional study. BMC Psychiatry. 2014;14(14):303.
    1. Cosco TD, Prina M, Stubbs B, Wu YT. Reliability and validity of the Center for Epidemiologic Studies Depression Scale in a population-based cohort of middle-aged U.S. adults. J Nurs Meas. 2017;25(3):476–485.
    1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
    1. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289–294.
    1. Etter JF, Hughes JR. A comparison of the psychometric properties of three cigarette withdrawal scales. Addiction. 2006;101(3):362–372.
    1. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180–191.
    1. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/ AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–110.
    1. Vidrine DJ, Kypriotakis G, Li L, et al. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug Alcohol Depend. 2015;147:76–80.
    1. Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013;57(4):608–615.
    1. Tseng TY, Krebs P, Schoenthaler A, et al. Combining text messaging and telephone counseling to increase varenicline adherence and smoking abstinence among cigarette smokers living with HIV: a randomized controlled study. AIDS Behav. 2017;21(7):1964–1974.
    1. Althoff KN, Rebeiro P, Brooks JT, et al. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014;58(8):1185–1189.
    1. Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: development of standard HIV core indicators across the U.S. Department of Health and Human Services. Public Health Rep. 2013;128(5):354–359.
    1. Reif S, Pence BW, Hall I, Hu X, Whetten K, Wilson E. HIV diagnoses, prevalence and outcomes in nine southern states. J Community Health. 2015;40(4):642–651.
    1. Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42(5):844–853.
    1. Ziefle M, Bay S. How older adults meet complexity: aging effects on the usability of different mobile phones. Behav Inf Technol. 2005;24(5):375–389.
    1. SafeLink Wireless Free Wireless Program Live Connected. [Accessed April 13, 2018]. Available from: .
    1. U.S. National Library of Medicine. Storytelling narrative communication intervention for smoking cessation in women living with HIV (WISE) [Accessed August 30, 2018]. Available from: .

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera